Compare Prudential Financial Inc (PRU) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential Financial Inc vs BIO-TECHNE Corp — how do they compare? Prudential Financial Inc trades at $117.5 (market cap $41.19B), while BIO-TECHNE Corp trades at $72.39 (market cap $11.34B). The key difference: Prudential Financial Inc is far larger — about 3.6× BIO-TECHNE Corp's market cap, and Prudential Financial Inc pays the higher dividend (4.69%). Which is the better fit depends on your goals.
| PRU | TECH | |
|---|---|---|
Market Cap | $41.19B | $11.34B |
Sector | Financials | Health |
52-Week High | $125.13 | $72.48 |
52-Week Low | $92.00 | $43.31 |
Enterprise Value | $69.96B | $11.36B |
Dividend Yield | 4.69% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PRU trades at $119.38, down 2.16% today, with a neutral technical outlook and mixed earnings history. The stock shows strong profitability with a 6.04% net margin and 12.46% ROE, while valuation metrics like a P/E of 10.82 and P/S of 0.64 appear attractive. Recent news highlights PGIM's ETF launches and conference participation, signaling strategic focus.
The outlook is cautious; analyst consensus is a Hold with a $113.20 target below the current price. Risks include volatile cash flows and high leverage, but steady dividends and earnings beats offer support. Upside depends on execution of cost reductions and capital-light growth amid economic uncertainty.
Bio-Techne (TECH) trades at $72.31, down 0.17% on the day, with a neutral technical signal and mixed earnings history. The stock is near the consensus price target of $71.86, with a pending acquisition by Merck KGaA at $73.00 per share. Recent Q4 2026 revenue beat estimates, but net income margin compression from 25.09% in 2023 to 14.96% in 2026 highlights profitability challenges. Operating cash flow remains stable around $290M, supporting dividend payments.
The outlook is balanced, with upside capped by the acquisition offer but supported by solid cash flow and analyst hold ratings. Risks include shareholder litigation and integration uncertainties post-acquisition. Earnings growth in diagnostics and spatial biology segments is a key catalyst, though high P/E of 62.33 suggests elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
